1. Product
Overview
1.1. Market
Definition
1.2. Scope
of the Market
1.2.1. Markets
Covered
1.2.2. Years
Considered for Study
1.2.3. Key
Market Segmentations
2. Research
Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validations
2.7. Assumptions
and Limitations
3. Executive
Summary
3.1. Overview
of the Market
3.2. Overview
of Key Market Segmentations
3.3. Overview
of Key Market Players
3.4. Overview
of Key Regions/Countries
3.5. Overview
of Market Drivers, Challenges, Trends
4. Voice
of Customer
5. Global
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
5.1. Market
Size & Forecast
5.1.1. By
Value
5.2. Market
Share & Forecast
5.2.1. By
Product (Instruments and Services, Consumables, Software)
5.2.2. By
Application (HIV Testing, HSV Testing, CT/NG testing, Syphilis testing,
Gonorrhea testing, Others)
5.2.3. By
Technology (Immunoassay, Molecular Diagnostics, Others)
5.2.4. By
Location of Testing (Laboratory Testing, Point of Care Testing, Others)
5.2.5. By
Region
5.2.6. By
Company (2023)
5.3. Market
Map
6. North
America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1. By
Product
6.2.2. By
Application
6.2.3. By
Technology
6.2.4. By
Location of Testing
6.2.5. By
Country
6.3. North
America: Country Analysis
6.3.1. United
States Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Application
6.3.1.2.3.
By Technology
6.3.1.2.4.
By Location of Testing
6.3.2. Canada
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Application
6.3.2.2.3.
By Technology
6.3.2.2.4.
By Location of Testing
6.3.3. Mexico
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Application
6.3.3.2.3.
By Technology
6.3.3.2.4.
By Location of Testing
7. Europe
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1. By
Product
7.2.2. By
Application
7.2.3. By
Technology
7.2.4. By
Location of Testing
7.2.5. By
Country
7.3. Europe:
Country Analysis
7.3.1. France
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Application
7.3.1.2.3.
By Technology
7.3.1.2.4.
By Location of Testing
7.3.2. Germany
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Application
7.3.2.2.3.
By Technology
7.3.2.2.4.
By Location of Testing
7.3.3. United
Kingdom Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By Product
7.3.3.2.2.
By Application
7.3.3.2.3.
By Technology
7.3.3.2.4.
By Location of Testing
7.3.4. Italy
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Application
7.3.4.2.3.
By Technology
7.3.4.2.4.
By Location of Testing
7.3.5. Spain
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Application
7.3.5.2.3.
By Technology
7.3.5.2.4.
By Location of Testing
8. Asia-Pacific
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1. By
Product
8.2.2. By
Application
8.2.3. By
Technology
8.2.4. By
Location of Testing
8.2.5. By
Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. India
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Application
8.3.1.2.3.
By Technology
8.3.1.2.4.
By Location of Testing
8.3.2. China
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Application
8.3.2.2.3.
By Technology
8.3.2.2.4.
By Location of Testing
8.3.3. South
Korea Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Application
8.3.3.2.3.
By Technology
8.3.3.2.4.
By Location of Testing
8.3.4. Australia
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Application
8.3.4.2.3.
By Technology
8.3.4.2.4.
By Location of Testing
8.3.5. Japan
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Application
8.3.5.2.3.
By Technology
8.3.5.2.4.
By Location of Testing
9. South
America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1.
By Product
9.2.2.
By Application
9.2.3.
By Technology
9.2.4.
By Location of Testing
9.2.5.
By Country
9.3. South
America: Country Analysis
9.3.1. Brazil
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Application
9.3.1.2.3.
By Technology
9.3.1.2.4.
By Location of Testing
9.3.2. Argentina
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Application
9.3.2.2.3.
By Technology
9.3.2.2.4.
By Location of Testing
9.3.3. Colombia
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Application
9.3.3.2.3.
By Technology
9.3.3.2.4.
By Location of Testing
10. Middle
East and Africa Sexually Transmitted Diseases (STD) Diagnostics
Market Outlook
10.1.
Market Size & Forecast
10.1.1. By
Value
10.2.
Market Share & Forecast
10.2.1. By
Product
10.2.2. By
Application
10.2.3. By
Technology
10.2.4. By
Location of Testing
10.2.5. By
Country
10.3.
MEA: Country Analysis
10.3.1. South
Africa Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Application
10.3.1.2.3.
By Technology
10.3.1.2.4.
By Location of Testing
10.3.2. Saudi
Arabia Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Application
10.3.2.2.3.
By Technology
10.3.2.2.4.
By Location of Testing
10.3.3. UAE
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Application
10.3.3.2.3.
By Technology
10.3.3.2.4.
By Location of Testing
11. Market
Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market
Trends & Developments
12.1.
Recent Development
12.2.
Mergers & Acquisitions
12.3.
Product Launches
13. Global
Sexually Transmitted Diseases (STD) Diagnostics Market: SWOT Analysis
14. Porter’s
Five Forces Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Products
15. Competitive
Landscape
15.1.
Becton Dickinson and Company
15.1.1. Business
Overview
15.1.2. Company
Snapshot
15.1.3. Products
& Services
15.1.4. Financials
(As Reported)
15.1.5. Recent
Developments
15.1.6. Key
Personnel Details
15.1.7. SWOT
Analysis
15.2.
F. Hoffmann-La Roche Ltd.
15.3.
Hologic, Inc.
15.4.
bioMérieux S.A.
15.5.
Abbott Laboratories Inc.
15.6.
Danaher Corporation
15.7.
Qiagen N.V.
15.8.
Thermo Fisher Scientific Inc.
15.9.
DiaSorin S.p.A
15.10.
Bio-Rad Laboratories, Inc.
16. Strategic
Recommendations
17. About
Us & Disclaimer